COMMUNIQUÉS West-GlobeNewswire

Yield10 Bioscience Names Sherri M. Brown, Ph.D., Former Monsanto Executive, as Special Commercial and Technical Advisor

13/12/2018 - 14:30

WOBURN, Mass., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new technologies to create step-change improvements in crop yield that enhance global food security, today [...]

Aleafia Health: A New LP with 22 Medical Clinics, 50K Patients and 98,000 kg Production -- CFN Media

13/12/2018 - 14:30

SEATTLE, Dec. 13, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

NHMRC to Fund Major Phase 2 Clinical Trial of Cynata’s Cymerus™ MSCs in Patients with Osteoarthritis

13/12/2018 - 14:15

MELBOURNE, Australia, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: CYP), a clinical-stage biotechnology company specialising in cell therapeutics, is pleased to announce that the Australian [...]

CLS Holdings USA Closes approximately $12 Million Private Placement of Convertible Debentures

13/12/2018 - 14:00

LAS VEGAS, Dec. 13, 2018 (GLOBE NEWSWIRE) -- CLS Holdings USA, Inc. (OTCQB: CLSH) “CLS,” a diversified cannabis company operating as Cannabis Life Sciences and an integrated cannabis producer and retailer in Nevada [...]

XBiotech Announces Publication of Post-Hoc Analysis for Phase III Colorectal Cancer Study

13/12/2018 - 14:00

Biomarkers Predict Significantly Higher Rates of Treatment Response to Bermekimab in Advanced Cancer Patients AUSTIN, Texas, Dec. 13, 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) announced today the publication [...]

Canntab Partners with Leading Surgeon to Conduct Pain Management Trial -- CFN Media

13/12/2018 - 14:00

SEATTLE, Dec. 13, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

Sport Endurance Appoints Michael Young to Board of Directors

13/12/2018 - 14:00

JERSEY CITY, N.J., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Sport Endurance, Inc. (OTCQB: SENZ) (the “Company”) is pleased to announce the appointment of Michael Young as Chairman of the Board of Directors. Mr. Young’s [...]

Inspire’s Health Profiles Identifies the Insights of Patients to Unlock Research Gaps

13/12/2018 - 14:00

Company invites new global academic collaborations to accelerate clinical research ARLINGTON, Va., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Inspire, the leading healthcare social network for patients and caregivers, is [...]

Orchard Therapeutics Announces the Build-out of New Gene Therapy Manufacturing Facility in California

13/12/2018 - 13:30

New facility expected to create more than 100 new jobs, supporting extensive gene therapy pipeline Enhances Orchard’s capacity to develop and deliver lentiviral vector and gene-corrected hematopoetic stem cells for wide [...]

HEXO Corp reports $6.7 million in gross revenue for the first quarter of new fiscal year

13/12/2018 - 13:11

Sales of $5.2 million for adult-use cannabis during the first two weeks of legalization in Canada Creation of Truss, a partnership with Molson Coors Canada in support of the Company’s objective to partner with Fortune [...]

HEXO Corp déclare des revenus bruts de 6,7 millions de dollars pour le premier trimestre du nouvel exercice

13/12/2018 - 13:11

Ventes de 5,2 millions de dollars de cannabis destiné au marché adulte au cours des deux premières semaines suivant la légalisation au Canada Création de Truss, un partenariat avec Molson Coors Canada à l’appui de l’ [...]

Altimmune Announces Clinical Program Updates and Plans for Pipeline Expansion

13/12/2018 - 13:01

GAITHERSBURG, Md., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics company, today announced updates to its clinical programs and plans to further expand its pipeline [...]

ProQR Announces Strategic Changes to the Management Team and Key New Hires

13/12/2018 - 13:00

LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 13, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of transformative RNA [...]

Hi Fidelity Genetics Closes Series A Financing to Automate Plant Breeding

13/12/2018 - 13:00

Top Ag Financiers Invest in AI-Platform to Bring Predictive Data Science to Crop Breeding DURHAM, N.C., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Hi Fidelity Genetics (HFG), a computational crop breeding company, announced it [...]

Rhythm Pharmaceuticals Announces First Patient Enrolled in Pivotal Phase 3 Clinical Trial Evaluating Setmelanotide in Bardet-Biedl and Alström Syndromes

13/12/2018 - 13:00

Company to host KOL Symposium focused on Bardet-Biedl Syndrome in New York City; live webcast beginning at 8:30am ET BOSTON, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a [...]

Antares Pharma Announces the Appointment of Peter S. Greenleaf to Company’s Board of Directors

13/12/2018 - 13:00

EWING, N.J., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced the appointment of Peter S. Greenleaf to the Company’s Board of Directors. Mr. Greenleaf has over 20 years of [...]

NeoGenomics Appoints Dr. Lawrence M. Weiss as Chief Scientific Officer

13/12/2018 - 13:00

FT. MYERS, Fla., Dec. 13, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today announced the appointment of Lawrence M. Weiss, M.D. as Chief [...]

Bellicum Pharmaceuticals Appoints Atabak Mokari as Chief Financial Officer

13/12/2018 - 13:00

HOUSTON, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]

Avinger Announces Successful Treatment of 500th Patient with Next-Generation Pantheris Device

13/12/2018 - 13:00

38% Year-over-Year Pantheris Revenue Growth in First Full Quarter of Launch REDWOOD CITY, Calif., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for [...]